Abstract
The various biological actions of substance P and related tachykinins/neurokinins are mediated by three different receptor types, which were named NK1, NK2 and NK3 during the Montreal Symposium in 1986 (Henry, 1987). The three receptors have been characterized pharmacologically (Regoli et al., 1987a, Regoli et al., 1988, Regoli et al., 1989), biochemically (Lavielle et al., 1988; Buck et al., 1991), and genetically (Nakanishi, 1991). In vivo activities have been attributed to each receptor by Maggi et al. (1987), Regoli et al. (1988), and Maggi et al. (1993). Cloning and sequencing of receptors and the study of receptor properties of mRNA expressed in special systems (Nakanishi, 1991) appear to validate the three physiological entities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abelli, L., Somma, V., Maggi, C. A., Regoli, D., Astolfi, M., Parlani, M., Rovero, P., Conte, B., and Meli, A. (1989) Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK-1 receptors. J. Auton. Pharmac. 9, 253–263.
Abelli, L., Maggi, C. A., Rovero, P., Del Bianco, E., Regoli, D., Drapeau, G., and Giachetti, A. (1991) Effect of synthetic tachykinin analogs on airway microvascular leakage in rats and guinea pigs: evidence for the involvement of NK-1 receptors. J. Auton. Pharmac. 11, 267–275.
Advenier, C., Rouissi, N., Nguyen, Q. T., Emonds-Alt, X., Breliere, J. C., Neliat, G., Naline, E., and Regoli, D. (1992) Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem. Biophys. Res. Comm. 184, 1418–1424.
Beresford, I. J. M., Birch, P. J., Hagan, R. M., and Ireland, S. J. (1991) Investigation into species variants in tachykinin NK-1 receptors by use of the non-peptide antagonist, CP-96,345. Br. J. Pharmacol. 104, 292–293.
Buck, S. H. and Shatzer, S. A. (1988) Agonist and antagonist binding to tachykinin peptide NK-2 receptors. Life Sci. 42, 2701–2708.
Buck, S. H., Van Giersbergen, P. K. M., and Burcher, E. (1991) Tachykinins and their receptors: pharmacology biochemistry and molecular biology advance a neuropeptide story to the forefront of science. Neurochem. Int. 18, 167–170.
Busse, R. and Mulsch, A. (1990) Calcium-dependent nitric oxyde synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265, 133–134.
Constantine, J. W., Lebel, W. S., and Woody, H. A. (1991) Inhibition of tachykinininduced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors. Naunyn Schmiedeberg’s Arch. Pharmacol. 344, 471–477.
Couture, R. and Cuello, C. A. (1984) Studies of the trigerminal antidronic vasodilatation and plasma extravasation in the rat. J. Physiol. 346, 273–285.
Couture, R. and Kerouac, R. (1987) Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist. Br. J. Pharmacol. 91, 265–273.
Couture, R., Laneuville, D., Guimond, C., Drapeau, G., and Regoli, D. (1989) Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn Schmiedeberg’s Arch. Pharmacol. 340, 547–557.
Devillier, P., Advenier, C., Drapeau, G., Marsac, J., and Regoli, D. (1988) Comparison of the effect of the epithelium removal and of an eukephalinase inhibitor on the neurokinin-induced contractions of guinea pig isolated trachea. Br. J. Pharmacol. 94, 675–684.
Dion, S., D’Orléans-Juste, P., Drapeau, G., Rhaleb, N.-E., Rouissi, N., Tousignant, C., and Regoli, D. (1987) Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sci. 41, 2269–2278.
D’Orléans-Juste, P., Dion, S., Mizrahi, J., and Regoli, D. (1985) Effects of peptides and nonpeptides on isolated arterial smooth muscles: role of endothelium. Eur. J. Pharmacol. 114, 9–21.
D’Orléans-Juste, P., Dion, S, Drapeau, G., and Regoli, D. (1986) Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur. J. Pharmacol. 125, 37–44.
D’ Orléans-Juste, P., Dion, S., Rhaleb, N.-E., Drapeau, G., and Regoli, D. (1987) Isolated arterial and venous vessels as selective pharmacological preparations for neurokinins, in Substance P and Neurokinins (Henry, J. L., Couture, R., Cuello, A. C., Pelletier, G., Quirion, R., and Regoli, D., eds.), Springer-Verlag, New York, pp. 125–128.
D’Orléans-Juste, P., Claing, A., Telemaque, S., Warner, T. D., and Regoli, D. (1991) Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. Eur. J. Pharmacol. 204, 329–334.
Drapeau, G., D’ Orléans-Juste, P., Dion, S., Rhaleb, N.-E., Rouissi, N., and Regoli, D. (1987) Selective agonists for substance P and neurokinin receptors. Neuropeptides 10, 43–54.
Drapeau, G., Rouissi, N., Nantel, F., Rhaleb, N.-E., Tousignant, C., and Regoli, D. (1990) Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems. Regul. Pept. 31, 125–135.
Emonds-Alt, X., Vilain, P., Goulaouic, P., Proietto, V., Van Broeck, D., Advenier, C., Naline, E., Neliat, G., Le Fur, G., and Brelière, J. C. (1992) A potent and selective non-peptide antagonist of the neurokinin A (NK-2) receptor. Life Sci. Pharmacol. Lett. 50, PL101–PL106.
Fujii, T., Murai, M., Morimoto, H., Hagiwara, D., Miyake, H., and Matsuo, A. (1992) Effect of a novel substance P antagonist, FK 888 on airway constriction and airway edema in guinea pigs. Neuropeptides 22, 24.
Garret, C., Carruette, A., Fardin, V., Moussaoui, S., Peyronel, J. F., Blanchard, J. C., and Laduron, P. J. (1991) Pharmacological properties of a potent and selective non-peptide substance P antagonist. Proc. Natl. Acad. Sci. USA 88,10,208–10,211.
Gitter, B. D., Waters, D. C., Bruns, R. F., Mason, N. R., Nixon, J. A., and Howbert, J. J. (1991). Species differences in affinities of neuropeptide antagonists for substance P receptors. Eur. J. Pharmacol. 197, 237–238.
Guiliani, S., Maggi, C. A., and Meli, A. (1988) NK-1 receptors mediate the tachykinin stimulation of salivary secretion: selective agonists provide further evidence. Eur. J. Pharmacol. 150, 377–379.
Guard, S. and Watson, S. P. (1991) Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Intern. 18,149–165.
Guard, S. and Watling, K. J. (1992) Interaction of the non-peptide NK-1 tachykinin receptor antagonist (±) CP-96,345 with L-type Ca’ channels in rat central cortex. Br. J. Pharmacol. 106, 37P.
Helke, C. J., Krause, J. E., Mantyh, P. W., Couture, R., and Bannon, M. J. (1990) Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors and regulatory mechanisms. FASEB J. 4, 1606–1614.
Henry, J. L. (1987) Discussion of nomenclature for tachykinins and tachykinin receptors, in Substance P and Neurokinins (Henry, J. L., Couture, R., Cuello, A.C., Pelletier, G., Quirion, R., and D. Regoli, eds), Springer-Verlag, New York, p. xvii.
Hultgardh-Nilsson, A., Nilsson, I., Jonzon, B., and Dalsgaard, C. J. (1988) Coupling between inositol phosphate formation and DNA synthesis in smooth muscle cells stimulated with neurokinin A. J. Cell Physiol. 137, 141–145.
Ignarro, L. J. (1989) Endothelium-derived nitric oxide actions and properties. FASEB J. 3, 31–36.
Ireland, S. J., Jordan, C. C., Stephens-Smith, M. L., and Ward, P. (1988) Receptors mediating the contractile response to neurokinin agonists in the guinea pig trachea. Regul. Peptides 22, 93–98.
Ireland, S. J., Bailey, F., Cook, A., Hagan, R. M., Jordan, C. C. and Stephens-Smith, M. L. (1991) Receptors mediating tachykinin-induced contractile responses in guinea pig trachea. Br. J. Pharmacol. 103, 1463–1469.
Jacques, L., Couture, R., Drapeau, G., and Regoli, D. (1989) Capillary permeability induced by intravenous neurokinins: receptor characterization and mechanism of action. Naunyn Schmiedeberg’s Arch. Pharmacol. 340, 170–179.
Jard, S. (1988) Mechanism of action of vasopressin and vasopressin antagonists. Kidney Intern. 34, S38–S42.
Jukic, D., Rouissi, N., Laprise, R., Boussougou, M., and Regoli, D. (1991) Neurokinin receptor antagonists: old and new. Life Sci. 49, 1463–1469.
Laneuville, O., Dorais, J., and Couture, R. (1988) Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat. Life Sci. 42, 1295–1305.
Lavielle, S., Chassaing, G., Ploux, O., Loeuillet, D., Besseyre, J., Julien, S., Marquet, A., Convert, O., Beaujouan, J. C., Torrens, Y., Bergstrom, L., Saffroy, M., and Glowinski, J. (1988) Analysis of tachykinin binding site interactions using constrained analogs of tachykinins. Biochem. Pharmacol. 37, 41–49.
Lee, C. M., Iversen, L. L., Hanley, M. R., and Sandberg, B. E. B. (1982) The possible existence of multiple receptors for substance P. Naunyn Schmiedeberg’s Arch. Pharmacol. 318, 281–287.
Maggi, C. A. (1990) Tachykinin receptors in the airways and lung: what should we block? Pharmacol. Res. 22, 527–540.
Maggi, C. A., Giuliani, S., Santicioli, P., Regoli, D., and Meli, A. (1987) Mini review. Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J. Auton. Pharmacol. 7, 11–32.
Maggi, C. A., Patacchini, R., Giuliani, S., Rovero, P., Dion, S., Regoli, D., and Giachetti, A. (1990a) Competitive antagonists discriminate between NK-2 neurokinin receptor subtypes. Br. J. Pharmacol. 100, 588–592.
Maggi, C. A., Patacchini, R., Giachetti, A., and Meli, A. (1990b) Tachykinin receptors in the circular muscle of the guinea pig ileum. Br. J. Pharmacol. 101, 996–1000.
Maggi, C. A., Giuliani, S., Ballati, L., Rovero, P., Abelli, L., Manzini, S., Giachetti, A., and Meli, A. (1990c) In vivo pharmacology of [13-Alaa)Neurokinin A(4–10), a selective NK-2 tachykinin receptor agonist. Eur. J. Pharmacol. 177, 81–86.
Maggi, C. A., Giuliani, S., Ballati, L., Lecci, A., Manzini, S., Patacchini, R., Renzetti, A. R., Rovero, P., Quartara, L., and Giachetti, A. (1991) In vivo evidence for tachykininergic transmission using a new NK-2 receptor selective antagonist, MEN 10376. J. Pharmacol. Exp. Therap. 257, 1172–1178.
Maggi, C. A., Patacchini, R., Rovero, P., and Giachetti, A. (1993) Tachykinin recep-tors and tachykinin receptor antagonists. J. Autonom. Pharmacol. 13, 23–75.
Masu, Y., Hakayama, K., Tamaki, H., Harada, Y., Kuno, M., and Nakanishi, S. (1987) cDNA cloning of bovine substance K receptor through oocyte expression system. Nature 329, 836–838.
McKnight, A. T., Maguire, J. J., Williams, B. J., Foster, A. C., Tridgett, R., and Iversen, L. L. (1988) Pharmacological specificity of synthetic peptides as antagonists at tachykinin receptors. Regul. Pept. 22, 127.
McKnight, A. T., Maguire, J. J., Elliott, N. J., Fletcher, A. E., Foster, A. C., Tridgett, R., Willliams, B. J., Longmore, J., and Iversen, L. L. (1991) Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists of tachykinin receptors. Br. J. Pharmacol 104, 335–360.
Morimoto, H., Murai, M., Maeda, Y., Hagiwara, D., Miyake, H., Matsuo, M., and Fujii, T. (1992) FR 113680, a novel tripeptide substance P antagonist with NK-1 receptor selectivity. Br. J. Pharmacol. 106,123–126.
Munekata, E., Kubo, K., Tanaka, H., and Osakada, F. (1987) Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles. Peptides 8, 169–173.
Nakanishi, S. (1991) Mammalian tachykinin receptors. Annu. Rev. Neurosci. 14, 123–136.
Nantel, F., Rouissi, N., Rhaleb, N.E., Jukic, D., and Regoli, D. (1991) Pharmacological evaluation of the angiotensin, kinin and neurokinin receptors on the rabbit vena cava. J. Cardiovasc. Pharmacol. 18, 398–405.
Nicolau, M., Sirois, M. G., Bui, M., Plante, G. E., Sirois, P., and Regoli, D. (1993) Plasma extravasation induced by neurokinins in conscious rats, receptor charac-terization with agonists and antagonists. Can. J. Physiol. Pharmacol. 71, 217–221.
Pernow, B. (1983) Substance P. Pharmacol. Rev. 35, 85–147.
Petitet, F., Beaujouan, J. C., Saffroy, M., Torrens, Y., Lavielle, S., Chassaing, G., Loeuillet, D., and Glowinski, J. (1992a) Un nouveau récepteur des tachykinines révélé par des analogs de la substance P dans l’iléon de cobaye. C.R. Acad. Sci. Paris 314, 299–303.
Petitet, F., Saffroy, M., Torrens, Y., Lavielle, S., Chassaing, G., Loeuillet, D., Glowinski, J., and Beaujouan, J.C. (1992b) Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides 13, 383–388.
Picard, P., Rouissi, N., Regoli, D., Gitter, B. D., Howbert, J. J., and Couture, R. (1993) Use of nonpeptide tachykinin receptor antagonists to substantiate the involvement of NK-1 and NK-2 receptors in a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 232, 255–261.
Regoli, D., D’ Orléans-Juste, P., Drapeau, G., Dion, S. and Escher, E. (1985) Pharmacological characterization of substance P antagonists, in Tachykinin Antagonists (Hakanson, R. and Sundler. F., eds.), Elsevier, Amsterdam, pp. 277–287.
Regoli, D., Drapeau, G., Dion, S., and D’Orléans-Juste, P. (1987a) Pharmacological receptors for substance P and neurokinins. Life Sci. 40, 109–117.
Regoli, D., Drapeau, G., Dion, S., and D’Orléans-Juste, P. (1987b) Receptors for neurokinins in peripheral organs, in Substance P and Neurokinins (Henry, J. L., Couture, R., Cuello, A. C., Pelletier, G., Quirion, R., and Regoli, D., eds.) Springer-Verlag, New York, pp. 99–107.
Regoli, D., Drapeau, G., Dion, S., and Couture, R. (1988) New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Tr. Pharmacol. Sci. 9, 290–295.
Regoli, D., Drapeau, G., Dion, S., and D’Orléans-Juste, P. (1989) Receptors for substance P and related neurokinins Pharmacology 38, 1–15.
Regoli, D., Nantel, F., Tousignant, C., Jukic, D., Rouissi, N., Rhaleb, N.-E., Telemaque, S., Drapeau, G., and D’Orléans-Juste, P. (1991) Neurokinin agonists and antagonists. Ann. NY Acad. Sci. 632,170–183.
Rouissi, N., Claing, A., Nicolau, M., Jukic, D., D’Orléans-Juste, P., and Regoli, D. (1993a) Substance P (NK-1 receptor) antagonists: in vivo and in vitro activities in rats and guinea pigs. Life Sci. 52, 1141–1147.
Rouissi, N., Jukic, D., D’Orléans-Juste, P., and Regoli, D. (1993b) A potent and long-acting NK-1 selective agonist. Life Sci. 52, PL103–PL106.
Rouissi, N., Nantel, F., Drapeau, G., Rhaleb, N. E., Dion, S., and Regoli, D. (1990) Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, bradykinin and angiotensin in guinea pig, hamster and rat urinary bladders. Pharmacology 40, 196–204.
Rovero, P., Pestellini, V., Patacchini, R., Giuliani, S., Santicioli, P., Maggi, C. A., Meli, A., and Giachetti, A. (1989a) A potent and selective agonist for NK-2 tachykinin receptor. Peptides 10, 593–595.
Rovero, P., Pestellini, V., Rhaleb, N-.E., Dion, S., Rouissi, N., Tousignant, C., Telemaque, S., Drapeau, G., and Regoli, D. (1989b) Structure-activity studies of neurokinin A. Neuropeptides 13, 263–270.
Snider, R. J., Constantine, J. W., Lowe III, J. A., Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. E., Desai, J. C., Vinick, F. J., Spencer, R. W., and Hess, H. J. (1991a) A potent non-peptide antagonist of the substance P (NK-1) receptor. Science 251, 435–437.
Snider, R. M., Longo, K. P., Drozda, S. E., Lowe III, J. A., and Leeman, S. E. (1991b) Effect of CP96,345, a non-peptide substance P receptor antagonist, on salivation in rats. Proc. Natl. Acad. Sci. USA 88, 10,042–10,044.
Sutter, M. C. (1990) Pharmacol. Rev. 42, 287–325.
Tschöppe, C., Picard, P., Culman, J., Prat, A., Itoi, K., Regoli, D., Unger, T., and Couture, R. (1992) Use of selective antagonists to dissociate the central cardiovascular and behavioral effects of tachykinins on NK-1 and NK-2 receptors in the rat. Br. J. Pharmacol. 107, 750–755.
Unger, T. L., Carolus, S., Demmert, G., Ganten, D., Lang, R. F., Maser-Gluth, C., Steinberg, H., and Veelken, R. (1988) Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circulation Res. 63, 812–820.
Watson, S. P. and Downes, C. P. (1983) Substance P-induced hydrolysis of inositol phospholipids in guinea pig ileum and rat hypothalamus. Eur. J. Pharmacol. 93, 245–253.
Watson, S. P. (1984) The action of substance Pon contraction, inositol phospholipids and adenylate cyclase in rat small intestine. Biochem. Pharmcol. 33, 3733–3737.
Xu, X. J., Maggi, C. A., and Wiesenfeld-Hallin, Z. (1991) On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat. Neuroscience 44, 483–490.
Yamamoto, T. and Yaksh, T. L. (1991) Stereospecific effects of a non-peptidic NK1 selective antagonist, CP-96,345: anti nociception in the absence of motor dysfunction. Life Sci. 49, 1955–1963.
Yokota, Y., Sasai, Y., Tanaka, K., Fujiwara, T., Tsuchida, K., Shigemoto, R., Kakizuka, A., Ohkubo, H., and Nakanishi, S. (1989) Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264, 17,649–17,652.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Regoli, D., Rouissi, N., D’Orléans-Juste, P. (1994). Pharmacological Characterization of Receptor Types. In: Buck, S.H. (eds) The Tachykinin Receptors. The Receptors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0301-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0301-8_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6699-0
Online ISBN: 978-1-4612-0301-8
eBook Packages: Springer Book Archive